Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer

N Engl J Med. 2017 Apr 13;376(15):1401-1403. doi: 10.1056/NEJMp1615697.
No abstract available

MeSH terms

  • Administration, Intravesical
  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / supply & distribution
  • Antineoplastic Agents / therapeutic use
  • BCG Vaccine / supply & distribution*
  • BCG Vaccine / therapeutic use
  • Drug Approval
  • Drug Costs / trends*
  • Drugs, Generic / supply & distribution*
  • Drugs, Generic / therapeutic use
  • Health Care Costs
  • Health Services Accessibility
  • Humans
  • United States
  • United States Food and Drug Administration
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • BCG Vaccine
  • Drugs, Generic